These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8962252)

  • 1. Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection.
    Platz KP; Mueller AR; Haller GW; Naumann U; Berg T; Fukomoto T; Lemmens HP; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3236-7. PubMed ID: 8962252
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
    Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of immunosuppression and acute rejection on hepatitis B recurrence.
    Platz KP; Mueller AR; Haller GW; Berg T; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1997; 29(1-2):509-10. PubMed ID: 9123107
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.
    Mueller AR; Platz KP; Bechstein WO; Blumhardt G; Lobeck H; Hop U; Neuhaus P
    Transplant Proc; 1994 Dec; 26(6):3637-9. PubMed ID: 7527984
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression is not related to the response to steroids in acute liver rejection.
    Bercedo J; Jiménez C; Moreno E; García MA; Palomo JC; Loinaz C; Marcello M; Moreno C; Chamorro A; Manzanera M
    Transplant Proc; 1995 Aug; 27(4):2328-9. PubMed ID: 7652830
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression does not enhance tumor growth after orthotopic liver transplantation for hepatoma.
    Steininger R; Herbst F; Függer R; Mühlbacher F; Fritsch A
    Transplant Proc; 1992 Dec; 24(6):2690-2. PubMed ID: 1334597
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic liver allograft dysfunction.
    Desai M; Neuberger J
    Transplant Proc; 2009 Mar; 41(2):773-6. PubMed ID: 19328977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection.
    Fabregat J; Fradera R; Figueras J; Rafecas A; Torras J; Martinez LaCasa J; Baliellas C; Casais L; Jaurrieta E
    Transplant Proc; 1994 Oct; 26(5):2697-9. PubMed ID: 7940845
    [No Abstract]   [Full Text] [Related]  

  • 9. BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejection.
    Mueller AR; Platz KP; Steinmüller T; Nüssler N; Neumann U; Gerlach H; Stoll C; Bechstein WO; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3103-5. PubMed ID: 8962203
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
    Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
    Vivarelli M; Cucchetti A; Piscaglia F; La Barba G; Bolondi L; Cavallari A; Pinna AD
    Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
    Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.
    Mueller AR; Platz KP; Blumhardt G; Bechstein WO; Steinmüller T; Christe W; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1995 Feb; 27(1):1117-20. PubMed ID: 7533359
    [No Abstract]   [Full Text] [Related]  

  • 16. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
    Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
    de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of immunosuppression with thymoglobuline pretreatment and hepatitis C virus recurrence in liver transplantation.
    De Ruvo N; Cucchetti A; Lauro A; Masetti M; Cautero N; Di Benedetto F; Dazzi A; Del Gaudio M; Ravaioli M; Zanello M; La Barba G; di Francesco F; Risaliti A; Ramacciato G; Pinna AD
    Transplant Proc; 2005; 37(6):2607-8. PubMed ID: 16182760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent HBV/HDV infections under different immunoprophylaxis protocols.
    Rimoldi P; Belli LS; Rondinara GF; Alberti A; DeCarlis L; Minola E; Pirotta V; Meroni A; Romani F; Sansalone V
    Transplant Proc; 1993 Aug; 25(4):2675-6. PubMed ID: 8356717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.